Similar articles

• Immunology in AIDS in 1990.

  Sela M. Sela M. AIDS. 1990;4 Suppl 1:S9-14. AIDS. 1990. PMID: 1983804 Review. No abstract available.
• HIV/AIDS vaccines: 2007.

  Robinson HL. Robinson HL. Clin Pharmacol Ther. 2007 Dec;82(6):686-93. doi: 10.1038/sj.clpt.6100408. Epub 2007 Oct 31. Clin Pharmacol Ther. 2007. PMID: 17971817 Review.
• Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.

  Betts MR, Gray CM, Cox JH, Ferrari G. Betts MR, et al. Expert Rev Vaccines. 2006 Aug;5(4):505-16. doi: 10.1586/14760584.5.4.505. Expert Rev Vaccines. 2006. PMID: 16989631 Review.
• Lymphocyte subsets and abnormalities in retrovirally infected mice.

  Popp DM. Popp DM. Crit Rev Immunol. 1990;10(2):73-112. Crit Rev Immunol. 1990. PMID: 1963783 Review. No abstract available.
• [Polyclonal B cell activation in infection caused by human immunodeficiency virus (HIV)].

  Exquis B, Perrin L, Link L, Scrignari V, Hirschel B, Zubler R, Miescher PA. Exquis B, et al. Schweiz Med Wochenschr. 1987 Nov 21;117(47):1863-5. Schweiz Med Wochenschr. 1987. PMID: 3501163 French.